Friday, July 29, 2022 The Zacks Research Daily presents the best research output of our analyst team. Today's Research Daily features new research reports on 16 major stocks, including Novartis AG (NVS), Duke Energy Corporation (DUK), and Boston Scientific Corporation (BSX). These research reports have been hand-picked from the roughly 70 reports published by our analyst team today. You can see all of today’s research reports here >>>
Novartis shares have outperformed the Zacks Large Cap Pharmaceuticals industry over the past year (+21.0% vs. -3.0%). The company’s second quarter performance was good on improvement in the lagging Sandoz business and cardiovascular drug Entresto’s momentum. Sandoz's performance was driven by growth in Europe on both launches and the recovery of the healthcare systems.
Consequently, the company also raised the full-year guidance for Sandoz. Drugs like Cosentyx, Entresto, Kesimpta, Zolgensma, Kisqali and Leqvio should continue to fuel growth and offset the impact of generic competition. The launch of additional drugs like Pluvicto, Piqray, Leqvio and Mayzent, and the label expansion of key drugs should also boost performance further.
The pipeline progress is impressive, and the company has some promising candidates. However, generic competition for key drugs and pipeline setbacks pose concerns.
(You can read the full research report on Novartis here >>>)
Duke Energy shares have outperformed the Zacks Utility - Electric Power industry over the year-to-date basis (+5.8% vs. +2.3%). The company is a premier utility service provider that invests heavily in infrastructure and expansion projects. During the 2022-2026 period, it projects to spend the capital of $63 billion, while $130 billion over the next decade.
It has lowered its carbon emissions by 44% since 2005 and is now expanding its 2050 net-zero goals to include Scope 2 and certain Scope 3 emissions. It expects a projects load growth to increase nearly 1.5% in 2022. Yet, its ability to achieve a net-zero target by 2050 at a cost-effective price could be at risk due to higher technological resources prices.
Also, the fluctuating energy prices may impact its results. A comparative analysis of the its trailing 12-month Enterprise Value/Sales ratio shows a gloomy picture that may concern investors.
(You can read the full research report on Duke Energy here >>>)
Boston Scientific shares have declined -9.7% over the past year against the Zacks Medical - Products industry’s decline of -29.0%. The company’s mounting costs and expenses are putting pressure on its margins. The ongoing macro-environment challenges related to increasing freight costs and higher direct labor wages continue to hamper business. Unfavorable foreign exchange deters growth. The upper end of the full-year adjusted EPS guidance has been reduced increasing concerns.
However, Boston Scientific ended the second quarter of 2022 on a bullish note with adjusted earnings and revenues surpassing the Zacks Consensus Estimate. The company registered a year-over-year improvement in organic sales, indicating a strong rebound in the legacy business from the pandemic mayhem. Organic revenues at each of its core business and geographies were up. The raised 2022 organic revenue guidance looks promising.
(You can read the full research report on Boston Scientific here >>>)
Other noteworthy reports we are featuring today include Norfolk Southern Corporation (NSC), Centene Corporation (CNC), and Cadence Design Systems, Inc. (CDNS).
Sheraz Mian Director of Research
Note: Sheraz Mian heads the Zacks Equity Research department and is a well-regarded expert of aggregate earnings. He is frequently quoted in the print and electronic media and publishes the weekly Earnings Trends and Earnings Preview reports. If you want an email notification each time Sheraz publishes a new article, please click here>>>
Cosentyx, Entresto Fuel Novartis (NVS) Amid Competition
Solid Investments Aid Duke Energy (DUK), Weak Solvency Woes
New Buyouts Aid Boston Scientific (BSX), Core CRM Grows
Dividends Lift Norfolk Southern (NSC) Despite Cost Woes The Zacks analyst is impressed with the company's efforts to pay out dividends even in the current uncertain scenario. High costs due to elevated oil price are, however, stunting bottom-line growth.
Centene (CNC) Rides on Growing Revenues Amid Rising Costs Per the Zacks analyst, solid Medicaid business, several contract wins and acquisitions continue to drive the company's revenues. However, elevated expenses remain a concern.
Energy Drinks Category Aids Growth at Monster Beverage (MNST) Per the Zacks analyst, Monster Beverage is experiencing continued strength in its energy drinks category driven by its Monster Energy brand. This is likely to continue throughout 2022.
United Rentals (URI) Rides on Buyouts Amid Supply Chain Woes Per the Zacks analyst, United Rentals gains from accretive acquisitions and solid end-market demand. However, unprecedented supply-chain disruptions are headwinds.
Growth Projects, Kirkland Buyout Aid Agnico Eagle (AEM) Per the Zacks analyst, the company will benefit from investment in growth projects to expand output and its acqusition of Kirkland Gold amid headwinds from higher costs.
Ecolab (ECL) Continues to Gain From its Business Strength The Zacks analyst is upbeat about Ecolab's strength in its business despite its operation in a stiff competitive space.
Uber (UBER) Rides on Delivery Business Amid Rising Expenses The Zacks Analyst likes Uber's efforts to expand its Delivery operations in response to the surge in business. However rising costs and expenses are concerning as they pose a threat to its bottomline
Cadence (CDNS) Benefits from Product Portfolio & Acquisitions Per the Zacks analyst, Cadence's performance is gaining from robust demand for the company's diversified product portfolio. Synergies from recent acquisitions also bode well.
Higher Rates, Loan Demand to Aid East West Bancorp (EWBC) Per the Zacks analyst, steady rise in loan demand, rising interest rates, a strong balance sheet and liquidity position will support East West Bancorp. Its capital deployments are sustainable.
Corcept (CORT) Rides High on Robust Korlym Sales Performance Per the Zacks analyst, solid performance of its approved drug, Korlym, has fueled growth for Corcept, and should be a top-line booster. The company's pipeline progress has been encouraging as well.
Crestwood (CEQP) to Suffer From Rising Operation Expenses The Zacks analyst is worried about Crestwood's rising operation and maintenance expenses limiting earnings. Also, lower cash-generating abilities show weakness in the partnership's operations.
Logitech (LOGI) Hurt by Soft Demand & Higher Component Costs Per the Zacks analyst, waning pandemic-led demand for peripherals and accessories will hurt Logitech's sales in the near-term while elevated component costs might weigh on profitability.
Soft Demand & Lower Lease Renewal Rate Ails Aaron's (AAN) Per the Zacks analyst, Aaron's weak demand stemming from continued inflation as well as lower lease portfolio size and lease renewal rates are likely to dent second half 2022 performance.
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Novartis AG (NVS) : Free Stock Analysis Report Boston Scientific Corporation (BSX) : Free Stock Analysis Report Duke Energy Corporation (DUK) : Free Stock Analysis Report Norfolk Southern Corporation (NSC) : Free Stock Analysis Report Cadence Design Systems, Inc. (CDNS) : Free Stock Analysis Report Centene Corporation (CNC) : Free Stock Analysis Report To read this article on Zacks.com click here. Zacks Investment Research
Here are the markets that will be open on Columbus Day, also recognized as Indigenous Peoples' Day, on Monday, Oct. 10.
The year 2022 has been a painful journey for semiconductor manufacturers. Following the example of AMD , Nvidia and Intel , which are the three main players in the sector, 2022 is a year to forget .Their valuations are in recession. Advanced Micro Devices (AMD) currently has a market value of $94.4 billion, which is a decrease of at least $83 billion compared to December 31, 2021.
PayPal is in trouble. "You are independently responsible for complying with all applicable laws in all of your actions related to your use of PayPal's services, regardless of the purpose of the use," the document, called "Acceptable Use of Policy," said.
Everyone knows that you should buy low and sell high if you want to turn a profit in the markets. The trick is finding the bottom, to know when to buy. Jim Cramer, the well-known host of CNBC’s ‘Mad Money’ program, sees the market bottom hitting in the next couple of weeks, making the end of October the right time for investors to buy in. Referring to some recent predictions by market technician Larry Williams, Cramer says, “The bear market is more or less… toast and, even if the current rally s
Tesla stock is forming a bearish head-and-shoulders pattern. And with CEO Elon Musk likely selling more stock to fund his Twitter purchase, shares of the electric-vehicle giant might have further to fall.
A market rally attempt is reeling as the indexes plunged on Friday's jobs report. Tesla, AMD and On Semi sold off.
For the retail investor, the only certainty of our current market environment is uncertainty. Volatility is up, and the main indexes are showing deepening losses. As if that wasn't enough, at least one market bull is turning a bit more pessimistic. JPMorgan strategist Marko Kolanovic has been one of the more bullish voices on Wall Street in recent months, but current conditions have him pushing the timeline back. While he still believes that the S&P 500 can hit 4,800, or a 32% gain from current
“The Fed will have no choice but to reliquefy the system,'' an event that is likely to happen by the end of the World Series, Minerd writes on Thursday.
If you buy one between now and the end of October, you’ll earn a composite interest rate of 9.62%.
The veteran telecom company is having a stellar year in many respects, but reason for concern has emerged.
(Bloomberg) -- Sign up for the New Economy Daily newsletter, follow us @economics and subscribe to our podcast.Most Read from BloombergRussia Races to Reopen Crimea Bridge Damaged in Fiery BlastPutin Orders Sakhalin-1 Project Transferred to Russian EntityMinecraft Star Dream Meets His Screaming Fans for First TimeFacebook Is Warning 1 Million Users About Stolen Usernames, PasswordsWall Street Is Missing the Risk to Stocks If Inflation Is BeatenGlobal finance chiefs gather in Washington in the co
“The thing about Finland is that when you ask a straight question you usually get a straight answer,” remarked one fan of Ms Marin
In Musk v. Twitter, a part of the business life of the richest man in the world is revealed. Private messages exchanged with his inner circle immerse us into his process when he conceives an idea. The messages were released by the Delaware Chancery Court as part of the proceedings between the two parties.
The right answer likely hinges on whether or not the Federal Reserve follows through with plans to raise its benchmark interest rate to 4.5% or higher, as market-based indicators and the Fed’s latest batch of projections anticipate. Global markets are on edge about the possibility of an emerging-markets crisis resulting from higher interest rates and a U.S. dollar at a 20 year high, or a slump in the housing market due to rising mortgage rates, or the collapse of a financial institution due to the worst bond market chaos in a generation. Fears that the Fed could cause something in the global economy or financial system to “break” have inspired some to question whether the Fed can successfully whip inflation by hiking interest rates by the most aggressive pace in decades without causing collateral damage.
Commodities trading means you're buying and selling raw materials rather than finished products (like a house) or financial assets (like stocks and bonds). Commodities are assets like corn, coffee, lumber and ore. One common form of commodities trading is investing … Continue reading → The post Gold vs. Silver Investments: Which Is Better? appeared first on SmartAsset Blog.
These companies have the fuel to continue piping income into their investors' pockets in the coming years.
Lifetime annuities, a kind of do-it-yourself pension that can provide you a guaranteed income until the day you die, have suddenly become a much, much better deal. The pooled longevity risk is what makes them so useful.
In this article, we discuss the 10 best EV battery stocks to buy in late 2022. If you want to see more stocks in this selection, check out the 5 Best EV Battery Stocks to Buy in Late 2022. The share of EV sales has taken up more than 5% of the total new automobile […]
The warehouse club has always been a little different when it comes to its policies on credit cards.
Most S&P 500 investors consider Tesla stock to be the ultimate investment. But it turns out you could do better — much better.